Search details
1.
Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 127(14): 2507-2514, 2021 07 15.
Article
in English
| MEDLINE | ID: mdl-33739471
2.
Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection.
Am J Transplant
; 21(4): 1622-1628, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33320429
3.
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Biol Blood Marrow Transplant
; 26(5): 936-942, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31926364
4.
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls.
J Neurovirol
; 26(2): 257-263, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31863400
5.
Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(6): e204-e208, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30930192
6.
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).
Biol Blood Marrow Transplant
; 25(12): 2388-2397, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31400502
7.
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation.
Haematologica
; 104(5): 929-936, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30655377
8.
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells.
Am J Hematol
; 93(5): 615-622, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29359451
9.
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.
Blood
; 123(15): 2333-42, 2014 Apr 10.
Article
in English
| MEDLINE | ID: mdl-24558201
10.
Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
Am J Hematol
; 91(5): 507-17, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26822317
11.
Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia.
Br J Haematol
; 170(6): 826-36, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26010568
12.
Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation.
Haematologica
; 105(4): e186-e189, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31471374
13.
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma.
Am J Hematol
; 90(3): 230-4, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25502635
14.
Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis.
Blood
; 120(4): 761-7, 2012 Jul 26.
Article
in English
| MEDLINE | ID: mdl-22692507
15.
Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.
Hematol Oncol
; 31(3): 136-42, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23060227
16.
Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution.
Am J Hematol
; 88(2): 120-9, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23349006
17.
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients.
J Clin Virol
; 165: 105519, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37321150
18.
Donor Cell Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: A Case Report and Literature Review.
Genes (Basel)
; 14(11)2023 Nov 16.
Article
in English
| MEDLINE | ID: mdl-38003028
19.
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study.
Transplant Direct
; 9(3): e1451, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36845852
20.
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.
Haematologica
; 97(8): 1272-7, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22371180